EcoR1 Capital, LLC
- SEC CIK
- 0001587114
- Latest filing
- Aug 14, 2026
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by EcoR1 Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −3,447,156−100.0% | Sold out | Holders |
| Q3 2025 | 3,447,156 | $78.0M | 3.8% | −8,448,652−71.0% | Reduced | Holders |
| Q2 2025 | 11,895,808 | $205.9M | 12.2% | 00.0% | Unchanged | Holders |
| Q1 2025 | 11,895,808 | $260.2M | 15.5% | +4,9650.0% | Added | Holders |
| Q4 2024 | 11,890,843 | $379.4M | 15.2% | 00.0% | Unchanged | Holders |
| Q3 2024 | 11,890,843 | $342.9M | 11.8% | +283,418+2.4% | Added | Holders |
| Q2 2024 | 11,607,425 | $445.3M | 13.6% | +250,000+2.2% | Added | Holders |
| Q1 2024 | 11,357,425 | $667.6M | 17.0% | +184,357+1.7% | Added | Holders |
| Q4 2023 | 11,173,068 | $668.8M | 17.4% | +273,209+2.5% | Added | Holders |
| Q3 2023 | 10,899,859 | $414.6M | 14.1% | +5,448,212+99.9% | Added | Holders |
| Q2 2023 | 5,451,647 | $496.6M | 13.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 5,451,647 | $359.6M | 11.6% | +268,216+5.2% | Added | Holders |
| Q4 2022 | 5,183,431 | $268.0M | 8.2% | 00.0% | Unchanged | Holders |
| Q3 2022 | 5,183,431 | $354.0M | 10.5% | 00.0% | Unchanged | Holders |
| Q2 2022 | 5,183,431 | $234.4M | 8.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 5,183,431 | $263.4M | 8.3% | +1,149,549+28.5% | Added | Holders |
| Q4 2021 | 4,033,882 | $190.7M | 6.1% | +4,033,882 | New | Holders |